Groupe Icare

Groupe Icare, based in France, provides specialized laboratory testing and consulting services tailored for the health sector, including microbiology, biocompatibility, toxicology, and validation services for medical devices and pharmaceuticals. Founded in 1995, Groupe Icare operates as a laboratory testing and consulting service provider focused on the health sector. The company has not undergone significant pivots in its business strategy and has maintained its focus on comprehensive testing and validation services for clients in Europe, South America, and globally. The company is not reported to have subsidiaries or be part of a larger parent organization.

Groupe Icare specializes in laboratory testing and consulting services, primarily focusing on the health sector. The company provides a wide range of offerings, including microbiology, biocompatibility, toxicology, and validation services. These services aim to ensure that medical devices and pharmaceutical products meet stringent regulatory requirements and safety standards before they are brought to market. The core client base comprises manufacturers of medical devices, pharmaceuticals (both human and veterinary), and biocides, among others, who require comprehensive testing and validation to navigate regulatory landscapes effectively.

Groupe Icare serves a diverse geographical market, with clients located in Europe, South America, and beyond, demonstrating its international reach and commitment to quality. Revenue generation for Groupe Icare is predicated on a B2B model, wherein the company engages with clients through contracts for laboratory testing and consulting services. The firm structures its transactions through a combination of service agreements and project-based contracts that cater to specific client needs, such as biocompatibility testing and microbiological analysis, ensuring that clients receive tailored solutions that align with their regulatory and operational requirements. In November 2025, CERTANIA Holding GmbH, a portfolio company of Summit Partners and Greenpeak Partners, acquired Groupe Icare.

This acquisition allows CERTANIA Holding GmbH to expand its service offerings. Groupe Icare plans to leverage this acquisition to enhance its product lines and explore new geographic markets, facilitating further growth in the laboratory testing and consulting space.